DeveloGen AG

DeveloGen AG

A pioneering biology-driven drug discovery company dedicated to advancing therapies for diabetes and obesity since 1995, based in Georgia, USA.

Founded 1997 2 employees Venture round Total: $62.48M Biotechnology, Health Care +1

DeveloGen AG is a pioneering biology-driven drug discovery company dedicated to advancing therapies for diabetes and obesity. Founded in 1997 and based in Georgia, USA, the company has been at the forefront of developing innovative treatments for these widespread health concerns. DeveloGen stands out in the biotechnology, health care, and health and wellness industries with its focused approach to addressing critical medical needs. The company's commitment to tackling diabetes and obesity is clearly reflected in its slogan, underlining its dedication to making a tangible impact on these prevalent health issues. In addition to its strong mission, DeveloGen has received notable Venture Round investment at 01 June 2007 from Thuja Capital, signifying confidence from established investors in the company's potential. As the company continues its breakthrough work in drug discovery, DeveloGen AG remains a compelling venture for investors interested in the healthcare and biotechnology sector. With its proven dedication and support from notable investors, DeveloGen is poised to make significant contributions to the fields of diabetes and obesity treatment.

Funding Stage	Amount	Investors	Lead Investors	Date
Venture Round	Undisclosed	1	Thuja Capital	01 Jun 2007
Grant	€475.00K	1	Office of the Chief Scientist	04 Jul 2006
Venture Round	Undisclosed	1	Omega Funds	01 Jan 2004
Series C	€19.00M	1	AlpInvest Partners	20 Nov 2003
Series B	€40.00M	5	Deutsche Venture Capital, Global Life Science Ventures +3	18 Apr 2001
Series A	$3.00M	2	Atlas Venture, Global Life Science Ventures	18 Jan 1998
Venture Round	Undisclosed	1	Techno Venture Management	01 Jan 1997

Funding Stage

Amount

Investors

Lead Investors

Date

Venture Round

Undisclosed

Thuja Capital

01 Jun 2007

Grant

€475.00K

Office of the Chief Scientist

04 Jul 2006

Venture Round

Undisclosed

Omega Funds

01 Jan 2004

Series C

€19.00M

AlpInvest Partners

20 Nov 2003

Series B

€40.00M

Deutsche Venture Capital, Global Life Science Ventures +3

18 Apr 2001

Series A

$3.00M

Atlas Venture, Global Life Science Ventures

18 Jan 1998

Venture Round

Undisclosed

Techno Venture Management

01 Jan 1997

FAQ About DeveloGen AG

A pioneering biology-driven drug discovery company dedicated to advancing therapies for diabetes and obesity since 1995, based in Georgia, USA.

DeveloGen AG was founded in 1997.

DeveloGen AG operates in Biotechnology, Health Care and Health and Wellness. Its work centres on drug discovery, biology-driven, therapies and diabetes.

DeveloGen AG has approximately 2 employees.

DeveloGen AG has completed 7 funding rounds, raising a total of $62.48M. The latest funding stage is Venture round.

Top alternatives and competitors to DeveloGen AG include Bilayer Therapeutics, Kojin Therapeutics, Nexo Therapeutics, Morphic Medical, Intellikine. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

DeveloGen AG and Bilayer Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About DeveloGen AG

Funding Rounds & Investors (7)

DeveloGen AG Alternatives & Competitors

FAQ About DeveloGen AG